Table 2.
Prognostic characteristics of patients with colorectal cancer.
| Characteristic | Univariate |
Multivariate |
||||
|---|---|---|---|---|---|---|
| n | 5-year OS rate (%) | p-value | HR | 95% CI | p-value | |
| Age (years) | 0.82 | |||||
| ≥60 | 163 | 67.2 | ||||
| <60 | 200 | 72.1 | ||||
| Sex | 0.12 | |||||
| Male | 221 | 72.5 | ||||
| Female | 142 | 71.7 | ||||
| Tumor site | 0.37 | |||||
| Colon | 137 | 70.4 | ||||
| Rectum | 226 | 69.6 | ||||
| Tumor size (cm) | 0.16 | |||||
| ≥5 | 136 | 69.3 | ||||
| <5 | 227 | 72.8 | ||||
| Tumor invasion depth | 0.02 | |||||
| T1 + T2 | 191 | 75.3 | ||||
| T3 + T4 | 172 | 69.2 | ||||
| Lymph node involvement | 0.01 | |||||
| N0 | 149 | 74.2 | ||||
| N1 | 214 | 67.6 | ||||
| Clinical stage (TNM) | 0.04 | 3.32 | 1.98–8.62 | <0.01 | ||
| I + II | 160 | 75.3 | ||||
| III | 213 | 6412 | ||||
| Pathological differentiation | 0.01 | 1.27 | 1.02–3.67 | 0.01 | ||
| Good/moderate | 218 | 75.1 | ||||
| Poor | 145 | 64.2 | ||||
| Serum miR-142-3p | 0.03 | 2.68 | 1.21–7.95 | <0.01 | ||
| Low | 236 | 67.4 | ||||
| High | 127 | 76.9 | ||||
OS, overall survival; HR, hazard ratio; CI, confidence interval; miR-142-3p, microRNA-142-3p.